A Medical Device Daily
Cohera Medical (Pittsburgh), a company commercializing biodegradable surgical adhesives, reported receiving a Phase 1 SBIR Award for $180,000 to develop a sprayable formulation of its lead product, TissuGlu, for use in plastic surgery.
Seroma formation is among the most common post-surgical complications, occurring in up to 50% of certain surgical procedures, according to Cohera.
It said the goal of the project is to create a strong, easy-to-use sprayable surgical adhesive to bond planar flaps of tissue and reduce fluid accumulation after surgery by eliminating dead space in the wound and maintaining tissues in position for natural healing.
"This is a significant step forward in the development of our lead product TissuGlu," said Patrick Daly, president/CEO, Cohera Medical. "The National Institutes of Health have recognized the innovative nature of our technology and the significant medical need for a product of this kind."
Dr. Eric Beckman, chief scientific officer and co-founder of Cohera, is the principal study investigator.
In contract news:
• OxySure Systems (Frisco, Texas) reported that it has entered into a lease agreement with Sinacola Commercial Properties for 16,200 square feet of space in Frisco.
The company also obtained an incentive package totaling $567,000 from Sinacola and the Frisco Economic Development Corporation (FEDC) for investment in infrastructure and related improvements to its new Frisco facility.
Pending completion of the build-out of the facility, early summer 2007, the company said it will utilize the building as its new corporate headquarters and consolidate its manufacturing assembly.
OxySure Systems develops specialty medical and respiratory products. The company has developed a third generation catalytic process and methodology to generate medically pure oxygen from inert powders.
• Andover Medical (Andover, Massachusetts), a single-source provider of orthopedic, podiatric and urological durable medical equipment and incontinence treatment solutions, said it has retained the services of the Equity Performance Group (EPG; Boston).
EPG will provide Andover with investor relations and business communications strategies addressing the financial community. An online investor page, featuring a one-page investment profile, is now available and will be updated to include the latest news, media clips and corporate marketing material of Andover Medical.